TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Vascular Therapies Stock

Vascular Therapies Stock

vasculartx.comHealthcareFounded: 2001Funding to Date: $74.51MM

Vascular Therapies is a late-stage biopharmaceutical company focused on developing the Sirolimus-eluting collagen implant for local, perivascular drug delivery.

Buy or sell Vascular Therapies stockLearn more about Vascular Therapies IPO
Register for Details

For more details on financing and valuation for Vascular Therapies, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Vascular Therapies.

Register Today

Team

Management Team

John McDermott
Chief Executive Officer & Board Member
Paul Barkofsky Ph.D
Vice President, New Product Development
Maureen Harrison
Vice President, Quality Assurance
Sriram Iyer MD
Founder, Chief Scientific Officer & Board Member
Rosanne Terraciano
Vice President, Operations

Board Members

Andrew Midler
Savitr Capital
Kiyoshi Takesue
Robert Flanagan
Dan Ryan
Gerald Dorros MD
The Gerrald Dorros and Myra S. Dorros Recovable Trust
Robert Croce
New Enterprise Associates
Sriram Iyer MD
Allan Tessler
John McDermott
Michael Bamberger
Somasundaram Subramaniam
New Science Ventures

Other companies like Vascular Therapies in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Cytonics
Sector
Healthcare
 
 
Precision Neuroscience
Sector
Healthcare
 
 

News

PR Newswire 09/09/2019
Vascular Therapies Announces Positive Preliminary Clinical Results from its AV Fistula Trials in Patients with Kidney Disease
/PRNewswire/ -- Vascular Therapies, a clinical stage biotechnology company, is developing Sirogen™, a proprietary sirolimus formulation for intraoperative...
Mass Device 10/15/2018
Vascular Therapies raises $12m for drug-eluting vascular access implant
Vascular Therapies has raised $12.4 million from 29 investors as part of a $21.1 million round, according to a document filed last week with the SEC. The Cresskill, N.J.-based company is developing a sirolimus-eluting collagen implant for patients with end-stage renal disease. The bioresorbable drug-delivery system is designed to keep open a portal of entry […]

Trending Companies

Frequently Asked Questions